摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(benzyloxycarbonyl)-N-methyl-L-glutamic acid | 42417-69-6

中文名称
——
中文别名
——
英文名称
N-(benzyloxycarbonyl)-N-methyl-L-glutamic acid
英文别名
N-Benzyloxycarbonyl-N-methylglutaminsaeure;α-N-Z-L-MeGlu;(2S)-2-[methyl(phenylmethoxycarbonyl)amino]pentanedioic acid
N-(benzyloxycarbonyl)-N-methyl-L-glutamic acid化学式
CAS
42417-69-6
化学式
C14H17NO6
mdl
——
分子量
295.292
InChiKey
HPBMLBGBAOGMJU-NSHDSACASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    494.1±45.0 °C(Predicted)
  • 密度:
    1.332±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    21
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    104
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(benzyloxycarbonyl)-N-methyl-L-glutamic acid 在 palladium on activated charcoal 硫酸氢气三乙胺焦碳酸二乙酯三氟乙酸 作用下, 以 四氢呋喃二氯甲烷乙酸乙酯N,N-二甲基甲酰胺 为溶剂, 反应 41.58h, 生成 (S)-2-[((S)-4-Carboxy-4-{4-[(2,7-dimethyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-methyl-amino]-benzoylamino}-butyryl)-methyl-amino]-pentanedioic acid
    参考文献:
    名称:
    Folate-Based Inhibitors of Thymidylate Synthase:  Synthesis and Antitumor Activity of γ-Linked Sterically Hindered Dipeptide Analogues of 2-Desamino-2-methyl-N10-propargyl-5,8-dideazafolic Acid (ICI 198583)
    摘要:
    In an effort to synthesize inhibitors of thymidylate synthase (TS) that do not undergo polyglutamation, a series of gamma-linked sterically hindered dipeptide analogues of 2-desamino-2-methyl-N-10-propargyl-5 ,8-dideazafolic acid (ICI 198583) was prepared. A methyl, ethyl, or propargyl group was incorporated into the gamma-glutamyl amide bond of gamma-linked L,L dipeptide derivatives of ICI 198583, such as ICI 198583-gamma-L-Glu. In addition, steric bulk was introduced on either side of the gamma-glutamyl bond of ICI 198583-gamma-L-Glu or ICI 198583-gamma-L-Ala. The resulting dipeptide analogues, e.g., ICI 198583-gamma-MeGlu and ICI 198583-gamma-Aib, were apparently stable to in vivo hydrolysis but poorer inhibitors of TS and L1210 cell growth. However, introduction of 7-Me, 2'-F substitution into the quinazoline nucleus gave significant improvement in the inhibitory activity against thymidylate synthase. Compounds 28-30, the 7-Me, 2'-F derivatives of ICI 198583-gamma-MeGlu, ICI 198583-gamma-EtGlu, and ICI 198583-gamma-PgGlu, respectively, were potent inhibitors of TS (Ki(iapp) = 0.21-1.1 nM) and L1210 cell growth (IC50 = 0.05-0.34 mu M) and were similar to that seen with the most potent gamma-linked L,D dipeptide derivatives of ICI 198583 previously synthesized. Furthermore, the low cross-resistance ratios for the L1210:R-D1694/L1210 cell line indicated that 28-30 do not undergo polyglutamation.
    DOI:
    10.1021/jm960878u
  • 作为产物:
    描述:
    N-methyl-L-glutamic acid氯甲酸苄酯碳酸氢钠 作用下, 反应 2.0h, 以75%的产率得到N-(benzyloxycarbonyl)-N-methyl-L-glutamic acid
    参考文献:
    名称:
    Folate-Based Inhibitors of Thymidylate Synthase:  Synthesis and Antitumor Activity of γ-Linked Sterically Hindered Dipeptide Analogues of 2-Desamino-2-methyl-N10-propargyl-5,8-dideazafolic Acid (ICI 198583)
    摘要:
    In an effort to synthesize inhibitors of thymidylate synthase (TS) that do not undergo polyglutamation, a series of gamma-linked sterically hindered dipeptide analogues of 2-desamino-2-methyl-N-10-propargyl-5 ,8-dideazafolic acid (ICI 198583) was prepared. A methyl, ethyl, or propargyl group was incorporated into the gamma-glutamyl amide bond of gamma-linked L,L dipeptide derivatives of ICI 198583, such as ICI 198583-gamma-L-Glu. In addition, steric bulk was introduced on either side of the gamma-glutamyl bond of ICI 198583-gamma-L-Glu or ICI 198583-gamma-L-Ala. The resulting dipeptide analogues, e.g., ICI 198583-gamma-MeGlu and ICI 198583-gamma-Aib, were apparently stable to in vivo hydrolysis but poorer inhibitors of TS and L1210 cell growth. However, introduction of 7-Me, 2'-F substitution into the quinazoline nucleus gave significant improvement in the inhibitory activity against thymidylate synthase. Compounds 28-30, the 7-Me, 2'-F derivatives of ICI 198583-gamma-MeGlu, ICI 198583-gamma-EtGlu, and ICI 198583-gamma-PgGlu, respectively, were potent inhibitors of TS (Ki(iapp) = 0.21-1.1 nM) and L1210 cell growth (IC50 = 0.05-0.34 mu M) and were similar to that seen with the most potent gamma-linked L,D dipeptide derivatives of ICI 198583 previously synthesized. Furthermore, the low cross-resistance ratios for the L1210:R-D1694/L1210 cell line indicated that 28-30 do not undergo polyglutamation.
    DOI:
    10.1021/jm960878u
点击查看最新优质反应信息

文献信息

  • Thymidylate synthase inhibiting quinazolinones
    申请人:British Technology Group Limited
    公开号:US05561133A1
    公开(公告)日:1996-10-01
    Quinazolines of the formula ##STR1## wherein R.sup.1 is typically methyl, hydrogen or amino; R.sup.2 is typically methyl or propargyl; Ar is typically phenylene or 2'-fluorophenylene; R.sup.3 is the residue of a dipeptide substituted, typically by methyl, at position (a), (b) or (c), shown in the following partial formula: ##STR2## R.sup.4, R.sup.5, R.sup.6 and R.sup.8 are typically hydrogen, R.sup.7 is typically hydrogen or methyl; or a pharmaceutically acceptable salt, ester or amide thereof are of value in the treatment of cancer.
    式##STR1##中的喹唑啉,其中R.sup.1通常是甲基、氢或氨基;R.sup.2通常是甲基或丙炔基;Ar通常是苯基或2'-氟苯基;R.sup.3是二肽残基,通常在位置(a)、(b)或(c)处被甲基等取代,如下部分式所示:##STR2##R.sup.4、R.sup.5、R.sup.6和R.sup.8通常是氢,R.sup.7通常是氢或甲基;或其药学上可接受的盐、酯或酰胺在癌症治疗中具有价值。
  • [EN] 4-IMIDAZOLIDINONES AS KV1.5 POTASSIUM CHANNEL INHIBITORS<br/>[FR] 4-IMIDAZOLIDINONES UTILISÉS COMME INHIBITEURS DES CANAUX POTASSIQUES KV1.5
    申请人:WYETH CORP
    公开号:WO2009079624A1
    公开(公告)日:2009-06-25
    The present teachings relate to 4-imidazolidinones of Formula (I) Insert formula here as it appears in written form in the specification (I) which are useful as Kv1.5 potassium channel inhibitors providing atrial-selective antiarrhythmic activity. The present teachings further relate to compositions and methods for treating atrial-selective antiarrhythmia.
    本教导涉及到公式(I)中的4-咪唑啉酮。这些化合物可作为Kv1.5钾通道抑制剂,提供房性选择性抗心律失常活性。本教导还涉及治疗房性选择性抗心律失常的组合物和方法。
  • <i>N</i>-Methylamino Acids in Peptide Synthesis. II. A New Synthesis of <i>N</i>-Benzyloxycarbonyl, <i>N</i>-Methylamino Acids
    作者:John R. McDermott、N. Leo Benoiton
    DOI:10.1139/v73-286
    日期:1973.6.15

    Reaction of N-benzyloxycarbonyl derivatives of aliphatic amino acids, and threonine, aspartic, and glutamic acids whose side-chains were protected with the t-butyl group, gave the corresponding N-methylamino acid derivatives in good yields. The methionine derivative could be obtained by using only one mol of methyl iodide. Derivatives of threonine, and aspartic and glutamic acids whose side-chains were not protected could not be methylated. Analysis of the crude products of methylation in three cases showed that they contained 0–1% of racemized material.

    N-苄氧羰基衍生物与保护有叔丁基侧链的脂肪族氨基酸、苏氨酸、天冬氨酸的反应,产生相应的N-甲基氨基酸衍生物,收率较高。甲硫氨酸衍生物可以仅使用一摩尔的碘甲烷获得。苏氨酸、天冬氨酸的衍生物,其侧链未受保护的情况下无法进行甲基化。对三种情况下甲基化的粗产品进行分析显示,含有0-1%的消旋杂质。
  • SULPHOSTIN ANALOGUES AND PROCESSES FOR THE PREPARATION OF SULPHOSTIN AND ANALOGUES THEREOF
    申请人:ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI
    公开号:EP1184388B1
    公开(公告)日:2003-07-30
  • DIPEPTIDYLQUINAZOLONES AS ANTI-CANCER AGENTS
    申请人:BRITISH TECHNOLOGY GROUP LIMITED
    公开号:EP0631576A1
    公开(公告)日:1995-01-04
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物